CCNA is accelerating progress in dementia research

CCNA provides the infrastructure and support that facilitates collaboration amongst Canada’s dementia researchers and clinicians.

What is CCNA’s mission

The Canadian Consortium on Neurodegeneration in Aging (CCNA) provides the infrastructure and support that facilitates collaboration amongst Canada’s top dementia researchers and clinicians. CCNA is the premier hub for Alzheimer’s disease and dementia research in Canada, and a global leader in research on all aspects of neurodegenerative diseases from prevention to treatment to improving the quality of life of those living with the disease.

Brain showing colorful neurons

Read our news

This is where we share all news, milestones, people we celebrate, and CCNA projects and activities.

  • May 20, 2025

    Save the date!

  • May 13, 2025

    Upcoming webinar – Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research

  • April 16, 2025

    CCNA is now accepting poster and Tik-Talk submissions for its annual conference in October 2025

Partner organizations

More than a financial investment, CCNA’s Partner Organizations share the vision of leading in the prevention, treatment, and management of the neurodegenerative diseases of aging. CCNA is a Government of Canada initiative, also supported by several national, provincial and nonprofit organizations.

Illustration of elderly people on a park bench
CCNA - CCNV logo

Receive the latest news

Stay updated with the latest research developments from CCNA-CCNV. Our news section provides insights into cutting-edge studies, advancements in dementia care, and key findings in brain health research.